1.
Mirikizumab – a new option in the treatment of inflammatory bowel diseases. Prospect. Pharm. Sci. [Internet]. 2024 Sept. 23 [cited 2026 Nov. 9];22(3):178-85. Available from: https://prospects.wum.edu.pl/index.php/pps/article/view/262